Veena Hoffman

Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study

Veena Hoffman, Jesper Hallas, Marie Linder et al. · Drug Safety · 2021 · 24 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans

Veena Hoffman, Remon Abu‐Elyazeed, Cheryl Enger et al. · Human Vaccines & Immunotherapeutics · 2018 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study

Teresa A. Simon, Samy Suissa, Mary Lou Skovron et al. · Seminars in Arthritis and Rheumatism · 2023 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study

Veena Hoffman, Fei Xue, Stephen M. Ezzy et al. · Cephalalgia · 2019 · 11 citations

Life Sciences, Neurology, Pharmacotherapy +17

Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery

Veena Hoffman, Kathleen Mortimer, Kyra Mulder et al. · Current Medical Research and Opinion · 2021 · 10 citations

Medicine, Maxillofacial Surgery, Implant Imaging +13